<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28159985</article-id>
<article-id pub-id-type="pmc">6078594</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw326</article-id>
<article-id pub-id-type="publisher-id">ddw326</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Methyl-CpG binding-protein 2 function in cholinergic neurons mediates cardiac arrhythmogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Herrera</surname>
<given-names>José A.</given-names>
</name>
<xref ref-type="aff" rid="ddw326-aff1">1</xref>
<xref ref-type="aff" rid="ddw326-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ward</surname>
<given-names>Christopher S.</given-names>
</name>
<xref ref-type="aff" rid="ddw326-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wehrens</surname>
<given-names>Xander H.T.</given-names>
</name>
<xref ref-type="aff" rid="ddw326-aff1">1</xref>
<xref ref-type="aff" rid="ddw326-aff3">3</xref>
<xref ref-type="aff" rid="ddw326-aff4">4</xref>
<xref ref-type="aff" rid="ddw326-aff5">5</xref>
<xref ref-type="aff" rid="ddw326-aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neul</surname>
<given-names>Jeffrey L.</given-names>
</name>
<xref ref-type="aff" rid="ddw326-aff1">1</xref>
<xref ref-type="aff" rid="ddw326-aff2">2</xref>
<xref ref-type="aff" rid="ddw326-aff5">5</xref>
<xref ref-type="aff" rid="ddw326-aff6">6</xref>
<xref ref-type="aff" rid="ddw326-aff7">7</xref>
<xref ref-type="aff" rid="ddw326-aff8">8</xref>
<xref ref-type="corresp" rid="ddw326-cor1"></xref>
<!--<email>jneul@ucsd.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddw326-aff1">
<label>1</label>Interdepartmental Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, USA</aff>
<aff id="ddw326-aff2">
<label>2</label>Jan and Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, TX, USA</aff>
<aff id="ddw326-aff3">
<label>3</label>Cardiovascular Research Institute</aff>
<aff id="ddw326-aff4">
<label>4</label>Departments of Medicine</aff>
<aff id="ddw326-aff5">
<label>5</label>Molecular Physiology and Biophysics</aff>
<aff id="ddw326-aff6">
<label>6</label>Neuroscience</aff>
<aff id="ddw326-aff7">
<label>7</label>Human and Molecular Genetics</aff>
<aff id="ddw326-aff8">
<label>8</label>Pediatrics, Baylor College of Medicine, Houston, TX, USA</aff>
<author-notes>
<corresp id="ddw326-cor1"><label>*</label>To whom correspondence should be addressed at: Jeffrey L. Neul, Current Address: 9500 Gilman Drive, M/C 0626, University of California, San Diego, La Jolla, CA, USA. Tel: 92093-0626; Fax: 858-822-3684; Email: <email>jneul@ucsd.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>15</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date iso-8601-date="2016-10-18" pub-type="epub">
<day>18</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>25</volume>
<issue>22</issue>
<fpage>4983</fpage>
<lpage>4995</lpage>
<history>
<date date-type="received">
<day>20</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>9</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>9</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="ddw326.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Sudden unexpected death occurs in one quarter of deaths in Rett Syndrome (RTT), a neurodevelopmental disorder caused by mutations in <italic>Methyl-CpG-binding protein 2</italic> (<italic>MECP2</italic>). People with RTT show a variety of autonomic nervous system (ANS) abnormalities and mouse models show similar problems including QTc interval prolongation and hypothermia. To explore the role of cardiac problems in sudden death in RTT, we characterized cardiac rhythm in mice lacking <italic>Mecp2</italic> function. Male and female mutant mice exhibited spontaneous cardiac rhythm abnormalities including bradycardic events, sinus pauses, atrioventricular block, premature ventricular contractions, non-sustained ventricular arrhythmias, and increased heart rate variability. Death was associated with spontaneous cardiac arrhythmias and complete conduction block. Atropine treatment reduced cardiac arrhythmias in mutant mice, implicating overactive parasympathetic tone. To explore the role of MeCP2 within the parasympathetic neurons, we selectively removed MeCP2 function from cholinergic neurons (MeCP2 ChAT KO), which recapitulated the cardiac rhythm abnormalities, hypothermia, and early death seen in RTT male mice. Conversely, restoring MeCP2 only in cholinergic neurons rescued these phenotypes. Thus, MeCP2 in cholinergic neurons is necessary and sufficient for autonomic cardiac control, thermoregulation, and survival, and targeting the overactive parasympathetic system may be a useful therapeutic strategy to prevent sudden unexpected death in RTT.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01HD062553 (JLN)</award-id>
<award-id>U54HD083092</award-id>
<award-id>P30HD024064</award-id>
<award-id>R01HL089598</award-id>
<award-id>R01HL091947</award-id>
<award-id>R01HL117641</award-id>
<award-id>R25GM56929</award-id>
<award-id>T32GM088129</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Cynthia and Anthony Petrello Scholar fund at the Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital (JLN), the International Rett Syndrome</named-content>
</funding-source>
<award-id>#2813 (JLN)</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">American Heart Association</named-content>
</funding-source>
<award-id>13EIA14560061</award-id>
<award-id>14PRE18710063</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health or the Eunice Kennedy Shriver Child Health and Human Development Institute (NICHD)</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="13"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>